A previously unrecognized role for a cell surface receptor may open new therapeutic options for the treatment of fibrotic diseases.

Understanding the roles of various immune cells that reside in the gut lining could shed light on inflammatory bowel diseases.

Meena Madhur, MD, PhD, has received a Presidential Early Career Award for Scientists and Engineers.

The immune receptor NOD1 may be a prime target for preventing or treating H. pylori infections — the most significant risk factor for stomach cancer, Vanderbilt researchers have discovered.

Larry Marnett and colleagues have explored the role of two enzymes in metabolizing molecules associated with cell proliferation, inflammatory processes and neurological diseases.

Vanderbilt investigators have discovered that certain microRNAs — "telegram"-like signals — increase after the induction of allergic airway inflammation.

Cancer Research UK has awarded a 20-million-pound grant (about $25 million U.S.) to a team of international investigators, including Vanderbilt’s James Goldenring, MD, PhD, to study inflammation-related cancers.